Costs study in Alzheimer's disease;Estudio de costes en la enfermedad de Alzheimer

Revista Clinica Espanola

Volumn 204, Issue 2, 2004, Pages 64-69

  Atance Martinez J C ^a,c   Yusta Izquierdo, A ^b   Grupeli Gardel, B E ^b  

^a Hospital Provincial Ortiz de Zarate   (Spain)

^b HOSPITAL UNIVERSITARIO DE GUADALAJARA   (Spain)

^c NONE   (Spain)

Author keywords

Alzheimer; Cost

Indexed keywords

ANTIDEPRESSANT AGENT; ANXIOLYTIC AGENT; BENZODIAZEPINE DERIVATIVE; PROTEIN DERIVATIVE; VASODILATOR AGENT; VITAMIN;

AGE DISTRIBUTION; AGED; AGING; ALZHEIMER DISEASE; ANALYTICAL ERROR; ANAMNESIS; ARTICLE; COMORBIDITY; COMPUTER SYSTEM; CONSULTATION; CONTROLLED STUDY; COST OF ILLNESS; DEVELOPED COUNTRY; DISEASE SEVERITY; DRUG USE; FEMALE; GENERAL HOSPITAL; HEALTH CARE COST; HEALTH CARE SYSTEM; HOSPITAL COST; HOSPITALIZATION; HUMAN; INCIDENCE; INDEPENDENCE; MAJOR CLINICAL STUDY; MALE; NURSING HOME; PENSION; REGISTER; SANITATION; SEX DIFFERENCE; SOCIAL SUPPORT; SOCIOECONOMICS; SPAIN; UNIVERSITY HOSPITAL;

EID: 1942539807     PISSN: 00142565     EISSN: None     Source Type: Journal    
DOI: 10.1157/13058799     Document Type: Article

References (25)

1. Alzheimer A. Uber eine eigenartige Erkangkung der Hirnirinde. Allgemaine Zeotschrift fur Psychiatrie und Psychisch-Gerichtliche Medizin 1907;64:146-8.
2. Alzheimer A. En inglés en: Arch Neurol 1967;21:109-10.
3. Blessed G, Tomlinson BE, Roth M. The association between quantitative measures of dementia and of senile change in the cerebral gray matter of enderly subjects. Br J Psychiatry 1968;114:797-811.
4. Small GW, Rabins PV, Barry PB, Buckholtz NS, Dekosky ST, Ferris SH, et al. Diagnosis and treatment of Alzheimer disease and related disorders: consensus statement of the American Association of Geriatric Psychiatry. The Alzheimer's Association and American Geriatrics Society. JAMA 1997;278:1363-71.
5. Benke T. Two forms of aparaxia in Alzheimer's disease. Cortex 1993; 29:715-25.
6. Patterson MB, Schnell A, Martin RJ, Méndez MF, Smyth KA, Whitehouse PJ. Assesment of psychiatric symptoms in Alzheimer's disease. J Geriatr Psychiatry Neurol 1990;3:21-30.
7. Ernst RL, Hay JW. The US economic and social costs of Alzheimer's disease revisited. Am J Public Health 1994;84:1261-4.
8. Herbert LE, Scherr PA, Beckett LA, et al. Age specific incidence of Alzheimer's disese in a community population. JAMA 1995;273:1354-9.
9. Li G, Silverman JM, Smith CJ, et al. Age onset and familial risk in Alzheimer's disease. Am J Psychiatry 1995;152:424-30.
10. Breitner JC. Inflamatory processes and antiinflamatory drugs in Alzheimer's disease: a current appraisal. Neurobiol Aging 1996;17:789-94.
11. Paganini-Hill A, Henderson VW. Estrogen replacement therapy and risk of Alzheimer's disease. Arch Int Med 1996;156:2213-7.
12. Caro JJ, Getsios D, Raggio G, et al. Predicting long term implications for the course of Alzheimer's disease from short therm clinical trials results. [Abstrac 7]. Neurology outcomes research: current science and future directions. Programs and Abstracts of 125th Annual Meeting of the American Neurological Association. Boston: Massachusetts; 2000.
13. Salom JR, López A, Tudela O, López L, Sais J. Centro de día polivalente. Características de la población beneficiaria. Estadística descriptiva. Geriátrika 1999; 156(8):39-40.
14. Baker AA, Byrne RJ. Another style of psychogeriatric service. Br J Psychiatry 1977;130:123-6.
15. Greene JG, Timbury GC. A geriatric psychiatry day hospital service: a five year review. Age Ageing 1979;8:49-53.
16. Jones IG, Munbodh R. An evaluation a day hospital for the demential elderly. Health Bull 1982;40:10-5.
17. Atance JC, Ancochea J, Jiménez ML, Sanz C, Olivar M, Grupeli Gardel BE, et al. Unidad Médica Ambulatoria: casuí stica y complejidad en APG's y estancias evitadas. Med Preventiva 2000; 6(1):5-11.
18. Morán M, Atance JC, Isasia T, Sanz J, Martín E, Ancochea J, et al. Actividad ambulatoria: hospital de día. Urgencias (observación) y consultas externas analizados mediante APG's. Med Preventiva 2000;6(3):13-22.
19. Durán A. Los costes invisibles de la enfermedad. Madrid: Fundación BBV. Universidad Complutense; 2000.
20. Casado Marín D. Los efectos del envejecimiento demográfico sobre el gasto sanitario: mitos y realidaries. Gac Sanit 2000:15(2):154-63.
21. Martínez Lage M, Selmes M. La enfermedad de Alzheimer. Medicina y Ciencia. Fundación Española de Alzheimer; 2000.
22. Atance Martínez JC, Grupeli Gardel BE, Moreno Rodríguez FJ, de los Ríos Pérez C, García Calvo J. Cuantificación económica de los costes de la cardiopatía isquémica en un área de salud. Med del Trabajo 1997;6(6):329-34.
23. Cano Maillo T, Gálvez Sañola R. Aproximación al coste del trasplante hepático en el Hospital Ramón y Cajal. Rev Adm Sanit 1998;2(5): 103-17.
24. Gracia D. Ética de la eficiencia. Err: Amor JR, Ferrando J, Ruiz J, editores. Ética y gestión sanitaria. Fundación Sanitas. Comillas: 2000.
25. Martín Carrasco M, Abad Gutiérrez R, Nadal Álava S. Instituciones intermedias en el tratamiento de las demencias y otros trastornos psiquiátricos de la vejez: el Centro de Día Psicogeriátrico. Rev Esp Geriatr Gerontol 1991;26(Suppl 2):39-45.